Evaluating the feasibility and safety of 48-h short-stay pathway for robot-assisted laparoscopic partial nephrectomy: a propensity score-matched analysis Authors: Caihong Tang, Ningping Chu, Chenghao Shi, Zhongwen Chang, Taoyue Zhao, Hong He, Yiman Zhang, Lingling Jing Published: 2026 ABSTRACT AbstractObjectiveTo compare perioperative outcomes between the 48-h short-stay pathway and traditional inpatient management for patients undergoing robot-assisted partial nephrectomy (RAPN), and to evaluate the feasibility, safety, recovery efficiency, and economic benefits of the 48-h short-stay pathway.MethodsThis retrospective study included 175 patients who underwent RAPN between February 2022 and June 2024. Patients were assigned to a 48-h short-stay group (n = 60) or a traditional inpatient group (n = 115). A 1:1 propensity score matching (PSM) was conducted to balance baseline characteristics, including age, sex, BMI, comorbidities, tumor features, surgeon identity, and surgical year. Perioperative outcomes, recovery indicators, complications, and medical costs were compared.ResultsAfter PSM, 53 matched pairs were analyzed. The short-stay group showed significantly shorter operative time, less intraoperative blood loss, shorter warm ischemia time, earlier mobilization, earlier oral intake, faster bowel function recovery, and shorter bed rest (all P < 0.05). The short-stay group had 71.7% of patients discharged on postoperative day (POD) 1 and 100% within 48 h, while the traditional group had 22.6% on POD1, 33.96% on POD2, and 43.4% on POD ≥ 3 (P < 0.001). Both total and postoperative hospital stays were significantly shorter in the short-stay group (2.00 vs. 6.00 days, P < 0.001), with lower hospitalization costs (P < 0.001). Postoperative creatinine was lower in the short-stay group (P = 0.023), while creatinine change was comparable (P = 0.063). Complication rates, emergency department visits, and 30-day readmission rates were similar between groups (all P > 0.05). The short-stay group had a significantly lower drain placement rate (P = 0.002) without increased adverse events.ConclusionThe 48-h short-stay pathway for selected patients undergoing RAPN is feasible and safe. It accelerates postoperative recovery, shortens hospital stay, reduces medical costs, and optimizes healthcare resource utilization, without compromising safety or oncological early outcomes.Keywords: Robot assisted partial nephrectomy, 48-hour short stay pathway, Feasibility, Safety, Propensity score-matched analysis, Postoperative outcomes Introduction Renal cell carcinoma (RCC) is one of the most lethal malignancies in the urinary system, accounting for approximately 2%–3% of adult cancers. Over the past decade, its global incidence has continued to rise at an annual rate of 0.7%–2%, making it a growing public health concern worldwide [1]. With advances in minimally invasive surgical techniques, robotic-assisted laparoscopic surgery (RALS) has been widely adopted in urological practice [2, 3]. In particular, robotic-assisted laparoscopic partial nephrectomy (RAPN) has become a cornerstone in the management of localized renal tumors due to its enhanced precision, three-dimensional visualization, and flexible yet reliable suturing capability [4]. Compared with traditional open surgery or pure laparoscopic approaches, RAPN offers significant advantages in reducing intraoperative bleeding, shortening hospital stay, and expediting postoperative recovery [5, 6]. Concurrently, short-stay (or day) surgery has gained widespread acceptance across multiple surgical disciplines as an efficient, safe, and cost-effective care model [7, 8]. Incorporating technically complex procedures such as RAPN into a short-stay pathway not only aligns with the principles of enhanced recovery after surgery (ERAS) in urology [9], but also offers a promising direction for optimizing healthcare resource utilization. To date, there remains a scarcity of reported studies evaluating the safety and feasibility of 48-h short-stay pathway RAPN in China. However, when directly comparing patient outcomes between different surgical admission pathways, confounding bias often arises due to imbalances in baseline characteristics. To mitigate this bias, our study employed propensity score matching (PSM). This method uses demographic and clinical covariates that show statistically significant intergroup differences to calculate a propensity score for each case, indicating the likelihood of receiving a particular surgical pathway. This approach balances the distribution of key baseline confounders between the matched groups, thereby approximating the conditions of a randomized trial and allowing for a more accurate estimation of the true effect attributable to the surgical pathway itself [10]. Based on propensity score matching, this study systematically evaluated the feasibility and safety of a 48-h short-stay pathway for RAPN by comparing perioperative indicators, complication rates, and short‑term outcomes between short-stay and traditional inpatient management. Our findings aim to provide evidence‑based data from China to support the optimization of clinical pathways and promote the standardized implementation of 48-h short-stay pathway for complex urological procedures. Methods Study design and participants This retrospective study enrolled patients undergoing RAPN and categorized them into two groups based on the admission pathway: the short-stay surgery group, managed under a 48-h short-stay pathway center protocol with a target discharge within 48 h postoperatively, and the traditional inpatient group, admitted through the standard ward pathway with a postoperative stay of 5–7 days. All patients received a uniform, ERAS-based perioperative care pathway covering the pre-hospital, preoperative, intraoperative, postoperative, and post-discharge phases. The study aimed to compare the impact of different admission pathways on perioperative recovery outcomes under the condition of homogeneous nursing intervention. A retrospective analysis was conducted on 175 patients who underwent RAPN in the Urology Department of a tertiary hospital in Zhejiang Province between February 2022 and June 2024. Based on the admission pathway, patients were categorized into a short-stay surgery group (n = 60) and a traditional inpatient group (n = 115). PSM was performed in a 1:1 nearest-neighbor matching ratio without replacement, with a caliper width of 0.02 on the logit scale to balance baseline characteristics. Covariates included age, sex, BMI, hypertension, diabetes, smoking, alcohol consumption, maximum tumor diameter, R.E.N.A.L. score, surgeon identity, and surgical year. Balance was evaluated using standardized mean differences (SMD) for all covariates before and after matching. Missing data were handled by complete-case analysis; no imputation was used. Inclusion Criteria: (1) Aged 18–80 years. (2) Diagnosed by renal MRI or CT and scheduled for initial robot-assisted partial nephrectomy. (3) Classified as American Society of Anesthesiologists (ASA) physical status ≤ II, without significant cardiopulmonary disease or other major comorbidities. (4) No use of medications affecting coagulation or hemodynamics within one week prior to surgery. (5) Absence of concurrent other malignancies. (6) Ability to comply with preoperative assessments and possess basic communication skills. Exclusion Criteria: (1) Presence of other malignancies or severe systemic diseases. (2) Incomplete medical data. (3) Intraoperative conversion to an alternative surgical procedure. This study was approved by the Institutional Review Board of The Second Affiliated Hospital, Zhejiang University School of Medicine (Approval No. [2024] Review and Research No. 1598). Outcomes Primary outcomes: Postoperative complications and postoperative serum creatinine level. Secondary outcomes: 30-day readmission rate and reoperation rate. Change in serum creatinine (postoperative vs. preoperative) and change in hemoglobin (postoperative vs. preoperative). Operative time and estimated intraoperative blood loss. Time to first ambulation, time to first oral intake, time to return of bowel function (flatus), and duration of postoperative bed rest. Total length of hospital stay, postoperative length of stay, total hospitalization costs, and drainage tube placement rate. All safety endpoints were clearly defined: Readmission was defined as unplanned admission to any hospital within 30 days after surgery. Emergency department (ED) visit referred to unplanned ED or urgent clinic visit within 30 days. Complications were graded according to the Clavien–Dindo classification and recorded at 30 and 90 days postoperatively. Complications were categorized as bleeding/transfusion, urinary leak, fever/infection, ileus, acute kidney injury (AKI), and venous thromboembolism (DVT/PE). Surgical procedure for RAPN After successful anesthesia, the patient was placed in a lateral decubitus position with the healthy side down. A urinary catheter was inserted, and the lumbar bridge of the operating table was elevated. The surgical field was routinely disinfected and draped. A 1.5 cm incision was made superior to the iliac crest under direct vision. The muscles were bluntly dissected with vascular forceps, and the retroperitoneal space was separated digitally. A retroperitoneal balloon dilator was introduced to create a working space. Under guidance, three trocars were placed: an 8-mm trocar at the subcostal anterior axillary line connected to the first robotic arm, an 8-mm trocar at the subcostal posterior axillary line connected to the second robotic arm, and a 12-mm trocar for the camera port. Pneumoperitoneum was established. An additional 12-mm trocar was placed 3 cm medial to the iliac crest as an assistant port. Robotic instruments, including scissors and Maryland bipolar forceps, were then attached to the corresponding arms. The retroperitoneal fat was dissected and cleared. The perirenal fascia was incised to expose the kidney and renal pedicle. The renal artery and ureter were carefully isolated. The renal artery was temporarily clamped with a non-traumatic vascular clamp. Renal parenchyma was incised at the level of the tumor until the tumor surface was reached. The tumor was completely excised along its pseudocapsule. The resection bed was closed with a running suture using a 1–0 barbed suture (Quill™). After releasing the vascular clamp, no significant bleeding was observed. Hemostatic agents were applied, and the tumor specimen was placed into an endobag for intact retrieval. The operative field was meticulously inspected for hemostasis. No active bleeding was noted. A drainage tube was placed. After verifying that all instruments and gauze counts were correct, the incisions were closed in layers, concluding the procedure.All procedures were performed using a uniformly retroperitoneal approach by two experienced surgeons. Data collection Patient demographic and clinical data were collected by their attending physicians or charge nurses. The time to first ambulation was specifically documented by the head nurse of the ward. Overall quality control throughout the study process was conducted by the departmental quality control team. Statistical analysis All statistical analyses were performed using R software (version 4.1.0).Continuous variables were non-normally distributed and are presented as median (interquartile range, IQR).Between-group comparisons were performed using the Mann–Whitney U test (unpaired) and Wilcoxon signed-rank test (paired). Categorical variables are presented as n (%) and compared using the χ2 test or Fisher’s exact test. Median differences and 95% bootstrap confidence intervals (CI) were reported as effect sizes. A two-sided P-value < 0.05 was considered statistically significant. Results Comparison of baseline characteristics before and after PSM A total of 175 patients who underwent robot-assisted partial nephrectomy were included in this study, comprising 115 in the traditional inpatient group and 60 in the 48-h short-stay pathway group. The baseline characteristics of the two groups before matching are summarized in Table 1. No significant differences were observed between the two groups in terms of age, sex, smoking history, alcohol consumption, place of residence, education level, or body mass index (BMI) (all P > 0.05), indicating comparability in sociodemographic characteristics. However, tumor complexity was significantly lower in the 48-h short-stay pathway group. Specifically, the median maximum tumor diameter was smaller [3.00 (2.00–3.70) cm vs. 3.50 (2.50–4.50) cm, P = 0.011], and the R.E.N.A.L. nephrometry score was also lower [6.00 (5.00–7.00) vs. 7.00 (5.00–8.00), P = 0.011] compared with the inpatient group. Preoperative serum creatinine and hemoglobin levels did not differ significantly between the groups (P > 0.05). Regarding comorbidities, the proportion of patients with diabetes was significantly lower in the 48-h short-stay pathway group [8.33% vs. 20.00%, P = 0.046]. Although the Charlson Comorbidity Index (CCI) did not reach statistical significance (P = 0.106), the 48-h short-stay pathway group showed a trend toward better health status, with a higher proportion of patients having a CCI score of 0 (81.67% vs. 66.96%). Table 1Baseline characteristicsTraditional inpatient group (n = 115)Short-stay group (n = 60)t/χ2valueP valueAge (years), median IQR59.00 (48.00–66.00)57.00 (47.75–62.00)1.2260.268Gender, n (%)0.0110.918 Female45 (39.13)23 (38.33) Male70 (60.87)37 (61.67)Smoking status, n (%)0.0500.823 No71 (61.74)36 (60.00) Yes44 (38.26)24 (40.00)Alcohol consumption, n (%)0.0610.805 No75 (65.22)38 (63.33) Yes40 (34.78)22 (36.67)Residence, n (%)3.0010.083 Rural56 (48.70)21 (35.00) Urban59 (51.30)39 (65.00)Education level, n (%)6.1080.296 Illiterate10 (8.70)5 (8.33) Primary school35 (30.43)10 (16.67) Junior high school24 (20.87)19 (31.67) Technicalsecondary school4 (3.48)2 (3.33) Senior high school14 (12.17)5 (8.33) College or above28 (24.35)19 (31.67)BMI (kg/m2), median IQR24.60 (22.40–26.66)24.07 (22.02–26.41)0.4890.484Maximum tumor diamete (cm), median IQR3.50 (2.50–4.50)3.00 (2.00–3.70)6.4710.011R.E.N.A.L. score, median IQR7.00 (5.00–8.00)6.00 (5.00–7.00)6.4040.011Preoperative serum creatinine (μmol/L), median IQR72.60 (62.75–84.65)72.05 (60.55–82.62)1.2350.266Preoperative hemoglobin (g/L), mean(SD)140.12(16.70)142.03(15.94)0.5330.466Hypertension, n (%)0.7720.379 No61 (53.04)36 (60.00) Yes54 (46.96)24 (40.00)Diabetes, n (%)3.9930.046 No92 (80.00)55 (91.67) Yes23 (20.00)5 (8.33)CCI, n (%)6.1240.106 077 (66.96)49 (81.67) 127 (23.48)7 (11.67) 27 (6.09)4 (6.67) ≥ 34 (3.48)0 (0.00) Baseline characteristics Technical secondary school After 1:1 propensity score matching with caliper matching, 53 well-balanced pairs were obtained. All baseline characteristics showed no significant differences between the matched groups (all P > 0.05), confirming successful balance (Table 2). The patient selection flowchart is presented in Fig. 1. Table 2Comparison of baseline characteristics before and after PSMBefore PSMAfter PSMtraditional inpatient group (n = 115)Short-stay group (n = 60)t/χ2 valueP valueSMDTraditional inpatient group (n = 53)short-stay group (n = 53)t/χ2valueP valueSMDMaximum tumor diameter (cm), median IQR3.50 (2.50–4.50)3.00 (2.00–3.70)6.4710.0110.3943.00 (2.30–4.10)3.10 (2.00–4.00)0.0050.9420.022R.E.N.A.L. score, median IQR7.00 (5.00–8.00)6.00 (5.00–7.00)6.4040.0110.4006.00 (5.00–8.00)6.00 (5.00–8.00)0.0730.7870.032Diabetes, n (%)3.9930.0460.339 < 0.0011 < 0.001 No92 (80.00)55 (91.67)48 (90.57)48 (90.57) Yes23 (20.00)5 (8.33)5 (9.43)5 (9.43) Comparison of baseline characteristics before and after PSM Study flowchart of patient selection. Among 209 eligible RAPN patients, 175 were enrolled, and 106 were included after 1:1 propensity score matching Comparison of perioperative and short-term outcomes after matching After 1:1 propensity score matching, 53 well-balanced pairs were included for analysis. Baseline characteristics were well balanced between the short-stay group and the traditional inpatient group (all P > 0.05). Perioperative surgical outcomes The short-stay group showed significantly better surgical efficiency with shorter operative time (90.00 [75.00–110.00] vs. 130.00 [85.00–160.00] min, P < 0.001) and less intraoperative blood loss (20.00 [20.00–20.00] vs. 20.00 [20.00–50.00] mL, P = 0.018). Median warm ischemia time (WIT) was significantly shorter in the short-stay group (17 [14–21] vs. 22 [18–26] min, P < 0.001). No significant difference was observed in clamping strategy distribution between groups (P = 0.465). Postoperative recovery outcomes The short-stay group achieved significantly earlier postoperative recovery, including earlier first ambulation (15.78 [13.07–19.53] vs. 30.68 [17.27–42.67] h, P < 0.001), earlier first oral intake (8.23 [5.18–11.85] vs. 11.00 [6.75–17.00] h, P = 0.030), faster return of bowel function (2.00 [2.00–2.00] vs. 2.00 [2.00–4.00] days, P = 0.023), and shorter postoperative bed rest (16.00 [13.00–20.00] vs. 35.00 [19.00–43.00] h, P < 0.001). Length of stay and discharge distribution Both length of stay and discharge timing were compared between groups. Regarding discharge timing, 71.7% of the short-stay group was discharged on POD1, 28.3% on POD2, and 0% on POD ≥ 3. In the traditional inpatient group, 22.6% were discharged on POD1, 33.96% on POD2, and 43.4% on POD ≥ 3 (P < 0.001). Pathological and oncological outcomes Pathological diagnosis showed benign tumors in 8 (15.1%) vs. 10 (18.9%) and malignant tumors in 45 (84.9%) vs. 43 (81.1%) patients in the short-stay and inpatient groups, respectively (P = 0.582). Positive surgical margin rate was 0% vs. 1.9% (P = 0.315). The Trifecta achievement rate was significantly higher in the short-stay group (88.7% vs. 75.5%, P = 0.040). Renal function outcomes Postoperative serum creatinine was significantly lower in the short-stay group (74.10 [61.30–91.00] vs. 87.80 [69.70–98.00] μmol/L, P = 0.023), while the change in creatinine (Δcreatinine) did not differ significantly between groups (P = 0.063). Postoperative hemoglobin and Δhemoglobin were comparable between groups (both P > 0.05). Drain management The drain placement rate was significantly lower in the short-stay group (P = 0.002). This protocolized drain omission was not associated with increased complications. 30-day and 90-day complications (Clavien–Dindo) The overall 30‑day complication rate was 5.7% in the short-stay group and 15.1% in the inpatient group (P = 0.115). No grade ≥ III complications occurred in the short-stay group. Rates of fever/infection, AKI, bleeding/transfusion, urinary leak, and ileus were all low and comparable between groups. Emergency department visits occurred in 1 (1.9%) vs. 4 (7.5%) patients (P = 0.147). One patient (1.9%) in the inpatient group was readmitted within 30 days; no reoperations were recorded in either group. No additional complications were observed at 90 days. Healthcare cost Total hospitalization cost was significantly lower in the short-stay group (55,987.08 vs. 60,589.87 CNY, P < 0.001). All detailed data are presented in Table 3. Table 3Postoperative and short-term outcomes after PSMTraditional inpatient Group (n = 53)Short-stay group (n = 53)Z valueP valuePostoperative serum creatinine (μmol/L), median IQR87.80 (69.70–98.00)74.10 (61.30–91.00)5.1460.023ΔSerum creatinine (μmol/L), mean(SD)8.86(14.45)4.32(10.07)3.5300.063Postoperative complications, n (%)0.1580.691 No31 (58.49)33 (62.26) Yes22 (41.51)20 (37.74)Postoperative hemoglobin (g/L), mean(SD)124.32(17.01)125.98(16.20)0.2650.608ΔHemoglobin (g/L), median IQR−15.00 (−18.00–12.00)−16.00 (−21.00–11.00)0.2080.649Duration of surgery (min), median IQR130.00 (85.00–160.00)90.00 (75.00–110.00)11.696 < 0.001Intraoperative blood loss (ml), median IQR20.00 (20.00–50.00)20.00 (20.00–20.00)5.6120.018Time to first ambulation (h), median IQR30.68 (17.27–42.67)15.78 (13.07–19.53)21.686 < 0.001Time to first oral intake (h), median IQR11.00 (6.75–17.00)8.23 (5.18–11.85)4.6970.030Postoperative bed rest duration (h), median IQR35.00 (19.00–43.00)16.00 (13.00–20.00)31.972 < 0.001Time to return of bowel function (days), median IQR2.00 (2.00–4.00)2.00 (2.00–2.00)5.1930.023Total length of hospital stay (days), median IQR6.00 (5.00–8.00)2.00 (2.00–2.00)77.812 < 0.001Postoperative length of stay (days), median IQR4.00 (3.00–5.00)2.00 (2.00–2.00)39.139 < 0.001Total hospitalization costs (yuan), median IQR60,589.87 (57,025.37–64,409.12)55,987.08 (54,624.05–58137.79)21.364 < 0.001Drain placement, median IQR1.00 (0.00–1.00)0.00 (0.00–1.00)9.8530.002Discharge timing, n (%)42.970 < 0.001POD00(0.00)0(0.00)POD112(22.64)38(71.70)POD218(33.96)15(28.30)POD ≥ 323(43.40)0(0.00)Warm ischemia time (min), median (IQR)22 (18–26)17 (14–21)10.224 < 0.001Clamping strategy, n (%)1.5280.465Total clamping36(67.92)28(52.80)Selective clamping12(22.64)18(33.96)Off-clamp5(9.43)7(13.21)Pathology, n (%)Benign10(18.87)8(15.09)0.3020.582Malignant43(81.13)45(84.91)0.3020.582Positive surgical margin, n (%)1(1.90)0 (0.00)1.0100.315Trifecta achievement, n (%)40(75.5)47 (88.7)4.2370.04030-day complications (Clavien–Dindo), n (%)Grade I4(7.55)2(3.77)0.7020.402Grade II3(5.66)1(1.87)1.0600.303Grade ≥ III1(1.87)0(0.00)1.0100.315Fever/infection3(5.66)2(3.77)0.2140.643Urinary leak1(1.87)0(0.00)1.0100.315Bleeding/transfusion1(1.87)0(0.00)1.0100.315Ileus1(1.87)0(0.00)1.0100.315AKI2(3.77)1(1.87)0.3430.558Emergency department visit, n (%)4(7.55)1(1.87)2.0980.14730-day readmission, n (%)1(1.87)0(0.00)1.0100.315 Postoperative and short-term outcomes after PSM Discussion Feasibility and safety of the short-stay pathway for RAPN As data indicate, short-stay surgeries are projected to increase by approximately 16% from 2016 to 2026 [11], highlighting this efficient, low-burden model. In this study, postoperative complication rates showed no significant difference between short-stay and traditional inpatient groups (P = 0.691). No 30-day readmissions or reoperations occurred in either group, confirming short-stay pathways do not elevate short-term safety risks. Berger et al. also reported low readmission rates in 30 short-stay laparoscopic radical prostatectomy cases [12]. Collectively, these findings support the expansion of short-stay surgery from low-risk to moderately complex urological procedures [13]. Baseline renal function was comparable between groups, with preoperative creatinine levels of 72.05 (60.55–82.62) μmol/L in the short-stay group and 72.60 (62.75–84.65) μmol/L in the inpatient group (P = 0.266). Postoperative creatinine was significantly lower in the short-stay group (P = 0.023), while Δcreatinine was similar between groups, suggesting equivalent renal functional change related to surgery [14]. Lower absolute postoperative creatinine in the short-stay group may relate to recovery environment, fluid management, early mobilization, or unmeasured confounders [14]. Thus, definite renal benefits of short-stay pathways require further study. However, comparable complications and readmissions confirm non-inferior safety versus traditional inpatient care. Intraoperative blood loss was lower in the short-stay group (P = 0.018), likely due to strict efficiency and quality standards in standardized short-stay protocols. RAPN’s 3D visualization and tremor filtration enable precise dissection, hemostasis, and suturing, reducing bleeding [15, 16]. Less blood loss lowers shock and anemia risks, preserves renal perfusion, and may alleviate postoperative renal injury [15, 16]. Overall, short-stay RAPN shows equivalent feasibility and safety to traditional inpatient management, consistent with Mehrazin et al. [17]. Notably, while the univariate analysis suggested that the significantly shorter operative time in the short-stay group (90 vs. 130 min) might be influenced by less complex tumors (lower R.E.N.A.L. scores) observed in the pre-matching cohort (Table 1), our PSM analysis rigorously balanced tumor complexity and surgeon identity. The persistence of this efficiency gain after matching indicates that the time reduction is primarily attributable to the standardization of the surgical pathway and cumulative team experience, rather than selection bias. This streamlined efficiency was associated with lower intraoperative blood loss and faster patient recovery. Core outcomes remained stable after adjustment. Enhanced recovery: alignment of the short-stay model with ERAS principles All enrolled patients received the same integrated perioperative care pathway, a standardized full-cycle nursing model implemented at our institution [18, 19]. Advances in medical models rely on scientific nursing management, providing a reliable foundation for short-stay pathways in complex urological surgeries. The 48-h short-stay pathway extends ERAS principles to complex urological procedures, optimizing perioperative care to promote early postoperative recovery [20]. In this study, the short-stay group showed significantly earlier ambulation, shorter bed rest, faster flatus return, and earlier oral intake than the traditional inpatient group (all P < 0.05). Early mobilization is a core ERAS component, preventing complications, accelerating gastrointestinal recovery, and enhancing patient self-efficacy [21]. Earlier ambulation in the short-stay group reflects effective multimodal analgesia, individualized anesthesia, and dedicated nursing support [22]. Earlier flatus return and faster oral intake illustrate successful ERAS implementation, including appropriate preoperative fasting, precise intraoperative fluid management, and early postoperative oral feeding [23]. These measures reduce abdominal distension and nausea, improving patient comfort. Furthermore, the short-stay group had a lower drain placement rate as a protocolized practice [24]. Selective drain omission in stable patients without bleeding or urinary leakage was not associated with increased complications, confirming its safety. The drain placement rate was significantly lower in the short-stay group (P = 0.002). Solodkyy et al. reported that 24.6% of short-stay surgery failures were related to drain placement [25], and Zhu et al. demonstrated that drain omission after laparoscopic cholecystectomy reduced inflammatory responses and minor complications [24]. Drains may not improve key outcomes but can lead to unnecessary interventions; thus, selective omission enhances patient comfort and safety. In conclusion, systematic implementation of ERAS principles in the short-stay pathway significantly improves perioperative recovery for RAPN patients. Health economic benefits and optimization of resource allocation Against the backdrop of mounting medical resource supply–demand tension, the short-stay pathway optimizes allocation via elevated efficiency, showing significant health economic advantages [26]. This study found that versus the traditional inpatient group, the short-stay group had significantly shorter operative time and hospital length of stay, with markedly lower total hospitalization costs (both P < 0.001). The main driver of reduced costs was the prominently shortened hospital stay (2.00 vs. 6.00 days, P < 0.001). This directly reduced fixed expenditures including bed occupancy, nursing manpower, and consumable use, while avoiding unnecessary tests and interventions linked to prolonged hospitalization, thus lowering over-treatment risk [22]. From a health system perspective, the short-stay model markedly improves utilization efficiency of medical resources [27]. It allows hospitals to treat more patients with existing resources, reallocating high-quality care toward more complex or inpatient-required cases, aligning closely with public hospital high-quality development policy [28]. For patients, shorter hospitalization reduces not only direct medical costs but also indirect expenses such as lost wages and caregiver support costs, significantly improving the overall healthcare experience. Thus, the short-stay pathway is warranted and worthy of broader promotion for patients undergoing RAPN. Limitations and future directions This study has several limitations. It is a single-center retrospective design with selection bias, as patients were highly selected (ASA ≤ II, low comorbidity, low-complexity tumors), limiting generalizability. Only a subset of all RAPN patients was eligible, reflecting strict pathway criteria. Follow-up was limited to 90 days, without long-term oncologic data. Future prospective, multi-center studies are needed to validate long-term safety, refine eligibility criteria, and evaluate patient-reported outcomes [29]. Despite these limitations, this study provides real-world evidence supporting short-stay RAPN as a feasible, safe, and efficient model of care. Conclusion In summary, the short-stay pathway for RAPN, facilitated by streamlined pathways and technological innovation, is feasible and safe. It effectively reduces operative time and length of hospital stay, accelerates patient recovery, and lowers the financial burden on patients. Author contributors Caihong Tang, Ningping Chu, Chenghao Shi, Zhongwen Chang: Conceptualization, methodology, software, formal analysis, writing-original draft and project administration. Lingling Jing, Hong He, Yiman Zhang: Writing-review & editing and visualization. Caihong Tang, Taoyue Zhao: Data curation. Acknowledgements We would like to express our sincere gratitude to the General Scientific Research Project of Zhejiang Provincial Department of Education in 2023 (Project No.: Y202352223) and the Scientific Research Project of Zhejiang Provincial Health Commission in 2022 (Project No.: 2022KY800) for their financial support. Meanwhile, we are deeply thankful to all the patients who participated in this study for their understanding and active cooperation. Abbreviations Robot-assisted partial nephrectomy Propensity score matching Renal cell carcinoma Robotic-assisted laparoscopic surgery Enhanced recovery after surgery Charlson comorbidity index Funding This work was supported by the General Scientific Research Project of Zhejiang Provincial Department of Education [grant number Y202352223]; the Medical and Health Science and Technology Plan Project of Zhejiang Province [grant number 2022503411]. Data availability The datasets employed and examined in this research can be obtained by contacting the corresponding author with a reasonable request. Declarations Conflict of interest The authors declare no competing interests. Footnotes Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The datasets employed and examined in this research can be obtained by contacting the corresponding author with a reasonable request.